NEW YORK – Global law firm Reed Smith today announced that it has advised Rising Pharma Holdings and Casper Pharma, collectively Rising Pharmaceuticals, on its joint sale to H.I.G. Capital, a leading global alternative investment firm with over $45 billion of equity capital under management.

Rising Pharmaceuticals develops and markets generic and specialty branded pharmaceutical products across various therapeutic categories. Casper Pharma is a specialty pharmaceutical company focused on commercialize pharmaceuticals products for cardiovascular, gastrointestinal, urological, pain management and ophthalmic markets.

The Reed Smith M&A team advising Rising Pharmaceuticals included partners Niket Rele, Anatoliy Rozental, and James Tandler and associates Nataly Laufer Sultan, Ethan Seery, and Simon Kliegman.

Additional details about this transaction can be found at